Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001871604-21-000002

Options or other derivatives

  • VP Corporate Controller acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Maranian Jeffrey R VP Corporate Controller 2021-11-11 Grant or award · Stock Option (right to buy) +50,000 50,000 D
Loading xslF345X03/wf-form4_163701118201148.xml…